Delivery Order SPE2DB20D1004-SPE2DB24FF1R7
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $11,400.42 firm fixed-price contract is for the supply of 4,565,699 units of Atomoxetine HCL 80 mg capsules to support federal healthcare programs. This order is a part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that Amerisourcebergen holds with DLA Troop Support Medical for delivering a wide range of...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of 18 mg capsules of the drug Atomoxetine HCL, with a ceiling value of $1,180.72 and a completion date of April 9, 2025. The contract is a Delivery Order, with a Firm Fixed Price pricing type. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp is the prime contractor, and there are no major...
- This federal contract award is for the delivery of Atomoxetine HCL 80 mg capsules to the Defense Logistics Agency (DLA). The contract has an ultimate completion date of September 19, 2024 and a ceiling value of $1,252.34. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on September 18, 2024. This is a delivery order contract with a firm fixed price pricing type. The contract is not designated under any set-aside program. Amerisourcebergen holds a...
- This federal contract award, valued at $1,699.95, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distributor, for the delivery of Atomoxetine HCL 40 mg capsules. The contract has a completion date of February 13, 2024 and is a firm fixed-price delivery order. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary...
- This federal contract award, with ID SPE2DB20D3104 and SPE2DB24FV5L3, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,858.04 fixed-price delivery order is for the supply of 4563940986 - Atomoxetine HCL 40 mg capsules, with a completion date of March 13, 2024. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., has a significant Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide Atomoxetine HCL 18 mg capsules. The award, with a ceiling value of $1,265.40, is structured as a delivery order under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a maximum value of up to $999,999,999 through December 2025. This IDC enables the DLA to efficiently procure a comprehensive range of medical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,603.09 firm fixed-price delivery order is for the provision of 4,563,867,448 units of the medication Atomoxetine HCL 25 mg capsules. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This is a delivery order contract awarded to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,000.60 firm fixed-price contract is for the supply of 4,565,670,077 units of Atomoxetine HCL 40 mg capsules, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has a completion date of September 5, 2024 and is not designated as a set-aside. Amerisourcebergen holds a larger...
- This federal contract award, with ID SPE2DB20D3104|SPE2DB23FV7G3, is for the delivery of the drug Atomoxetine HCL 40 mg capsules to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $1,431.20 and was awarded on June 12, 2023 to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical,...
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,255 units of Atomoxetine HCL 40 mg capsules. The contract has a Firm Fixed Price (FFP) pricing structure and a total ceiling value of $1,307.21. It was awarded on July 25, 2024 with a period of performance through July 26, 2024. This contract represents a delivery order under AmerisourceBergen's $999,999,999 Indefinite...
- SPE2DB20D1004Indefinite Delivery Contract
- SPE2DB20D1004-SPE2DB24FF1R7Delivery Order
This federal contract award, solicitation number SPE2DB20D1004|SPE2DB24FF1R7, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,992.79 firm fixed-price delivery order is for the supply of 80 mg Atomoxetine HCL capsules. The contract has an ultimate completion date of January 8, 2024 and was awarded on January 5, 2024. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical to provide a broad range of pharmaceutical products and medical supplies in support of military and veterans' healthcare programs. The contract has no set-aside designation, indicating it was awarded through full and open competition.